LPL Financial’s ImageneBio Inc IMA Stock Holding History

LPL Financial’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,000	Closed	-$20.8K	–	5367
2024 Q3	$20.8K	Buy	+1,000	New	+$20.2K	﹤0.01%	5081

Other funds holding IMA

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

LPL Financial's IMA Position: Q4 2024 in Review

LPL Financial sold out of ImageneBio Inc (IMA) in Q4 2024, closing a stake of 1,000 shares — an estimated $20.8K sold.

LPL Financial first reported a position in IMA in Q3 2024 and held it in 1 quarter. The position peaked at $20.8K in Q3 2024. 52 funds tracked by Wall St. Rank hold IMA as of Q4 2024.

LPL Financial reported no remaining ImageneBio Inc position as of Q4 2024 after selling out during the quarter.
LPL Financial sold 1,000 ImageneBio Inc shares in Q4 2024, an estimated $20.8K.
LPL Financial first reported a position in ImageneBio Inc in Q3 2024 and held it in 1 quarter.
LPL Financial's ImageneBio Inc position peaked at $20.8K in Q3 2024.
52 funds tracked by Wall St. Rank held ImageneBio Inc as of Q4 2024.

Based on LPL Financial's 13F filing for Q4 2024, filed 11 Feb 2025.